Mindmaze治疗机构正在全球范围开展工作,以确保偿还其先进的神经治疗系统的费用,目的是将患者的治疗范围扩大到美国以外。 MindMaze Therapeutics is working globally to secure reimbursement for its advanced neurotherapeutics, aiming to expand patient access beyond the U.S.

迈德梅兹治疗正在推进其全球战略, 以确保其下一代神经治疗药物的报销, 专注于与国际医疗保健系统保持一致, 以改善患者的接入. MindMaze Therapeutics is advancing its global strategy to secure reimbursement for its next-generation neurotherapeutics, focusing on aligning with international healthcare systems to improve patient access. 该公司正在与世界各地的监管机构和付款人合作,展示临床和经济价值,目的是简化其创新疗法的批准和覆盖面。 The company is working with regulators and payers worldwide to demonstrate clinical and economic value, aiming to streamline approval and coverage for its innovative treatments. 这项努力标志着在扩大美国以外的尖端神经疗法供应方面迈出的关键一步。 This effort marks a key step in expanding availability of cutting-edge neurological therapies beyond the U.S.